baber/WOPTO huggingface dataset:
Patent PT-1291322-E (PT)
Inventor: CHRISTOPHER TONKIN MARK
IPC: A23L1/00
Filed: 1999-02-04
Abstract: A process for germinating plant seeds and growing a seedling from such a germinated plant wherein water is provided by a water delivery system comprising a layer of hydrophilic membrane, such that water passes through the hydrophilic membrane to the growing medium depending on the moisture content of the growing medium. <IMAGE>
Patent PT-1372861-E (PT)
Title: Flotation machine
Inventor: NIITTI TIMO
IPC: B03D1/14
Filed: 2002-04-03
Abstract: The invention relates to a flotation machine, particularly to a flotation machine rotor, that is used for dispersing air, supplied via the rotor axis, to the surrounding slurry, and in which rotor there are formed alternating air ducts and slurry grooves, so that the ends of both the air ducts and the slurry grooves, projecting outwardly from the rotor, form the outer surface of the rotor According to the invention the air ducts ( 3,15 ) are arranged in the rotor at essentially equal distances, starting radially from the rotor outer surface, so that the air ducts ( 3,15 ) form in the center part of the rotor a space ( 6,17 ) for the slurry, in which space the slurry surrounding the rotor is to be made to flow along the slurry grooves ( 5, 16 ) provided in between the air ducts ( 3,15 ).
Patent PT-1392325-E (PT)
Inventor: PALEPU NAGESWARA R
IPC: A61K9/00
Filed: 2002-05-02
Abstract: The present invention relates to the treatment and prevention of bone diseases in humans, including osteoporosis in postmenopausal women, Paget's Disease and hypercalcemia, by administration of a bisphosphonate in an inhalation form. The invention also relates to pharmaceutical inhalation compositions suitable for the treatment and prevention of bone diseases.
Patent PT-1374923-E (PT)
Title: Porous implants with antibiotic coating, their preparation and use
Inventor: VOGT SEBASTIAN DR
IPC: A61K47/12
Filed: 2003-05-28
Abstract: Production of an antibiotic coating on a porous article comprises introducing a sparingly water-soluble antibiotic salt (I) into the pores of the article, where (I) is e.g. netilmicin laurate, myristate or dodecylsulfate, sisomicin laurate, myristate or dodecylsulfate, gentamicin laurate or myristate, clindamycin laurate, amikacin laurate, myristate or dodecylsulfate. Production of an antibiotic coating on a porous article comprises introducing a sparingly water-soluble antibiotic salt (I) into the pores of the article, where (I) is netilmicin laurate, netilmicin myristate or netilmicn dodecylsulfate, sisomicin laurate, sisomicin myristate or sisomicin dodecylsulfate, gentamicin laurate or gentamicin myristate, clindamycin laurate, amikacin laurate, amikacin myristate or amikacin dodecylsulfate, kanamycin laurate, kanamycin myristate or kanamycin dodecylsulfate, vancomycin laurate, vancomycin myristate or vancomycin dodecylsulfate, ciprofloxacin laurate or ciprofloxacin myristate or a vancomycin-teicoplanin or clindamycin-teicoplanin salt.
Patent PT-1420109-E (PT)
Title: A method and an apparatus for treating paper pulp
Inventor: LARSSON PER
IPC: D21C9/00
Filed: 2003-10-30
Abstract: A method and an apparatus for increasing form factor and tensile index in a dry paper pulp for sale which per se is produced in a paper pulp mill and comprises the steps of: raw materials intake, possible debarking and chipping, cooking, as well as bleaching of the paper pulp obtained therefrom to brightnesses of between 70 and 95 per cent ISO, whereafter the product is dried. According to the invention, the paper pulp is mechanically processed in the wet state after the bleaching and before the drying in a fibre shearing apparatus (1-6 weight per cent concentration) at a moderate pressure of from 100 to 750 kPa. <IMAGE>
Patent PT-1490383-E (PT)
Title: Methods and compositions for identifying and characterizing hepatitis c
Inventor: HOLLAND-STALEY CAROL
IPC: C07H19/00
Filed: 2003-03-11
Abstract: The invention provides novel methods and compositions for amplifying portions of the HCV genome. The nucleic acid sequences set forth as SEQ ID NOS:1-64 derived from HCV cDNA and functional equivalents thereof, kits containing same, and methods employing same, are useful for the identification and characterization of HCV in biological samples.
Patent PT-1648683-E (PT)
Title: Device for manufacturing a double-walled thermoplastic pipe with a connecting sleeve
Inventor: LUPKE MANFRED ARNO ALFRED
IPC: B29C48/09
Filed: 2004-06-23
Abstract: A device for manufacturing a double-walled thermoplastic pipe with a connecting sleeve has a molding tunnel with a succession of molds for forming a corrugated molding wall and a connecting sleeve, respectively. An extrusion device extrudes a first flexible tube into said molding tunnel and a second flexible tube into said first flexible tube. A first gas channel is arranged for generating a pressure between said first and second flexible tubes. A compressed-gas control device is connected to said first gas channel for generating a pressure p 1 or a pressure p 2 in said space between said first and second flexible tubes by compressed air emerging from said first gas channel. A second compressed-gas control device is connected to a second gas channel for guiding compressed gas onto an inner side of said second flexible tube. Said first pressure controller is connected to said first gas channel via a compressed-gas line that is connected to an additional compressed-gas reservoir for gas exchange therewith.
Patent PT-1532974-E (PT)
Title: Composition comprising 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Inventor: GRAEBER MICHAEL
IPC: A61K31/185
Filed: 2003-03-12
Abstract: The invention relates to pharmaceutical composition comprising 0.3% by weight of 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoic acid, for the treatment of dermatological ailments with an inflammatory or proliferative component.
Patent PT-1598340-E (PT)
Title: 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
Inventor: CHEN ZHENGMING
IPC: A61P27/16
Filed: 2002-04-18
Abstract: Compounds of formula (IV) as ORL1 modulators for the treatment of pain.
Patent PT-1847607-E (PT)
Title: Antibodies against the p51 protein
Inventor: IKAWA YOJI
IPC: A61K38/00
Filed: 1999-03-24
Abstract: A recombinant p51 protein comprising an amino acid sequence of SEQ ID NO: 1, wherein said recombinant p51 protein is expressed from a transformant with the p51 expression vector, an isolated antibody or fragment thereof binding specifically to said p51 protein and a kit comprising said antibody or fragment thereof.
Patent PT-2034456-E (PT)
Title: Device for feeding coins into the aperture in a coin-operated apparatus
Inventor: GAUSELMANN PAUL
IPC: G07D1/00
Filed: 2007-10-26
Abstract: The device has an auxiliary force-operated actuating drive (14) assigned to a coin receiver (10), where coins present in the coin receiver are transported to a coin receiving opening (7) by the actuating drive. The coin receiver has a coin conveying bar (13), which supplies the coins of the coin receiving opening in an overlaid stroke and horizontal translatory motion by the actuating drive. The conveying bar is raised by eccentric cams (21, 23) and horizontally moved by an eccentric cam (22), and has rectangle-shaped recesses and/or break-throughs (24-26).
Patent PT-2042459-E (PT)
Title: Stacking device for postal dispatches
Inventor: HUGUES DAMIEN
IPC: B07C3/06
Filed: 2008-09-22
Abstract: The device (40) has a conveying system (41) for conveying postal items (P) towards a stacker (42) in which the items are stacked one behind the other on a narrow surface along a certain longitudinal direction. A deflector (53) is provided between the conveying system and the stacker. The deflector is oriented in a slanting manner with respect to the conveying system to move apart an upper edge of the items with respect to the direction.
Patent PT-2111867-E (PT)
Title: Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines
Inventor: LEWANDROWSKI PETER
IPC: A61K38/08
Filed: 2009-04-23
Abstract: The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.
Patent PT-2289873-E (PT)
Title: Process for the preparation of iodopropargyl compounds
Inventor: KOOP BERND
IPC: C07C269/06
Filed: 2009-08-31
Abstract: Preparing iodopropargyl compound (I), comprises reacting a propargyl compound (II) with iodine and/or metal iodide in the presence of a base and under the use of chlorine. Preparing iodopropargyl compound of formula (I-C?=C-(CH 2) n-O-C(=O)-NH-R) (I), comprises reacting a propargyl compound of formula (C?=C-(CH 2) n-O-C(=O)-NH-R) (II) with iodine and/or metal iodide in the presence of a base and under the use of chlorine. R : H, optionally substituted 1-20C-alkyl, 2-20C-alkenyl, 6-20C-aryl or 3-20C-cycloalkyl; and n : 1-6.
Patent PT-706567-E (PT)
Inventor: ACHSTETTER TILMAN
IPC: C12R1/19
Filed: 1994-06-28
Abstract: The present invention relates to a peptide family designated as xenonins, wherein the representative members can be isolated from the substance secreted from the skin of Xenopus laevis, and having precious pharmacological properties. The present invention further relates to a method for preparing a peptide of the invention comprising transforming a cell with an isolated DNA fragment encoding the peptide, culturing the cell in a suitable medium and recovering the peptide of the invention from the culture.
Patent PT-751764-E (PT)
Inventor: COUVAL EMMANUELLE
IPC: A61K8/00
Filed: 1995-03-22
Abstract: PCT No. PCT/FR95/00350 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 22, 1995 PCT Pub. No. WO95/25507 PCT Pub. Date Sep. 28, 1995A retinal-containing cosmetic skin-care composition comprising an oil-in-water emulsion stabilized by BHT and a method for preparing same.
Patent PT-755265-E (PT)
Inventor: PAONI NICHOLAS F
IPC: A61K38/28
Filed: 1995-03-30
Abstract: Methods of enhancing myocardial contractility and cardiac performance in a mammal with congestive heart failure are disclosed. In a first method a mammal with congestive heart failure is treated by administering to the mammal an effective amount of a combination of growth hormone (GH) and insulin-like growth factor (IGF-I). A second method comprises administering to the mammal an effective amount of a combination of GH and IGF-I in the presence of an ACE inhibitor. This method results in enhancement of myocardial contractility and cardiac performance above the level achieved with ACE inhibition alone. Preferably the mammal is a human.
Patent PT-841299-E (PT)
Inventor: HUNG MICHAEL
IPC: B66F5/04
Filed: 1996-11-08
Abstract: A hydraulic circuit system for a jack comprises an inlet circuit, a return circuit and an overload protection circuit with a piston-cylinder assembly (4,10), a sequence valve (B), a safety valve (D) and a relief valve (C), the inlet circuit extending from an outer reservoir (2) via a check valve (A1) to an oil chamber (3) of a manual pump (20), the oil chamber (3) being connected to an inner oil chamber (41) formed in the piston rod (4) via another check valve (A2) to form a closed circuit. The oil chamber (3) of the pump (20) is connected to an inner reservoir (1) in the hydraulic cylinder (10) via a sequence valve (B), and the inner reservoir (1) is connected to the outer reservoir (2) via a check valve (A3). When the maximum effect capacity of the oil chamber (3) of the pump (20) is greater than or equal to that of the inner oil chamber (41) of the piston rod (4), a single touch of the pump (20) can raise the hydraulic jack to a required loading position under no load or light load conditions. <IMAGE>
Patent PT-919332-E (PT)
Inventor: VOGEL JOSEF
IPC: B24B41/04
Filed: 1997-11-24
Abstract: The arrangement has rotary driven tools (1). A tool holder (2) is radially displaceable wrt. a rotary driven holding body's (7) rotation axis. The tool holder may be driven rotatably about its axis (1') and is eccentrically rotatably mounted in a holding ring (3) which is also eccentrically rotatably mounted in the holding body, preferably so that the rotation axes (1',9) of the tool holder and holding body are coaxial in an inner end position. An Independent claim is also included for a use of the arrangement as the tool head of a robot.
Patent PT-875164-E (PT)
Inventor: GOTZE KARL
IPC: A43B7/32
Filed: 1998-04-21
Abstract: The lower shoe construction is designed especially for safety shoes. The heel includes an energy absorber (16) to protect against impulse- or mechanical shock injuries in the heel or ankle regions. The device has a stiff, elastic deformation characteristic, with a force/distance function having a steeply-rising onset and subsequently degressive form. Preferably, the energy absorbent material is an insert embedded in a soft elastic substance, especially polyurethane, used in the sole construction. The insert is hollow and made of two parts, joined together. It may be made in an injected plastic with hardness of 60-70 Shore-D, using e.g. polyamide, polypropylene and/or polyoxymethylene.
Patent PT-1053120-E (PT)
Inventor: SCHIFFERS HERBERT
IPC: B60J10/00
Filed: 1999-02-12
Abstract: The invention relates to a rubber elastic seal, especially for internal hinged doors in vehicles, comprising a back wall, an outer wall, an inner wall and a front wall. The seal has a front strip (102) extending from the inner to the outer side and standing out in a progressively slanted manner from the front face onward, in addition to a moveable sealing lip formed on the outer edge area of the front strip extending from the front side onwards. The sealing lip (150) is formed on a web section (140) of the outer wall and/or the front wall in a hinge-like articulation.
Patent PT-1101378-E (PT)
Title: Method for transmitting digital useful data
Inventor: LAPPE DIRK
IPC: G10L19/02
Filed: 1999-07-23
Abstract: The method involves transmission to an intermediate station, with channel decoding, and directing the transmission to the second network (20) : The data for transmission in a first communication network (10) are source coded, channel coded, and transmitted as a bit stream to an intermediate station (15) via a channel of the first network, in particular via a third telecommunication network. The data are channel decoded in the intermediate station and channel coded for transmission to the second network. The data are transmitted to the second mobile station (5). Signaling data are transmitted from the intermediate station to the second mobile station to indicate the type of coding. The data are channel decoded in the second mobile station and source decoded according to the signaling data.
Patent IE-860258-L (IE)
Title: Quinolone inotropic agents
IPC: C07D401/12
Filed: 1986-01-29
Abstract: Quinolone inotropic agents (and their pharmaceutically acceptable salts) of the formula:- 
<CHEM>
 where n is 0, 1 or 2; R<1> is selected from -NR<4>R<5>, -NR<4>CO(C1-C4 alkyl), -NR<4>CONR<4>R<5>, - NR<4>COOR<5>, S(O)m(C1-C4 alkyl), -SO2NR<4>R<5>, -NR<4>SO2R<5>, -OCONR<4>R<5>, -OCO(C1-C4 alkyl), -OR<5>, -OCH2.Het, -COOR<4>, -CONR<4>R<5> and Het min ; R<4> is H or C1-C4 alkyl and R<5> is H, C2-C4 alkyl or -CH2CH2N(C1-C2 alkyl)2, or R<4> and R<5> taken together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocyclic group optionally containing a further heteroatom or group selected from O, S and N-R<6> where R<6> is H or C1-C4 alkyl;
 m is 0, 1 or 2;
 Het is a 5- or 6-membered nitrogen-containing aromatic heterocyclic group attached by a carbon atom to the adjacent -CH2- group;
 Het min  is a 5- or 6-membered nitrogen-containing heterocyclic group;
 R<2>, which is attached to the 3-, 4-, 5-, 6-, 7- or 8-position, is H, C1-C4 alkyl, C1-C4 alkoxy, hydroxy, cyano, halo, CF3 or -NR<4>R<5> where R<4> and R<5> are as defined above;
 R<3> is H or C1-C4 alkyl;
 X is H, C1-C4 alkoxy, hydroxy, halo or CF3;
 and the dotted line between the 3- and 4-positions represents an optional bond;
 and the pharmaceutically acceptable salts of the compounds of the formula (I).
Patent IE-800318-L (IE)
Title: Classification of particulate material.
IPC: B03B/
Filed: 1980-02-19
Abstract: The apparatus disclosed includes a rotatable cylindrical vessel (1) with a concentrate outlet (14, 15) near its operatively lowest part and a particulate feed inlet (9, 10, 11) and a tailings outlet (18) above the concentrate outlet. A primary static member 6 in the form of a thin wall annular cylindrical member is inside the vessel (1) spaced by a small gap (7) from the cylindrical wall of the vessel. 
[EP0015679A1]
Patent IE-36190-L (IE)
Title: Nitrobenzyl sulfonates
IPC: C07C317/14
Filed: 1972-03-21
Abstract: 1334635 Nitrobenzyl sulphonates ELI LILLY & CO 18 April 1972 [19 April 1971] 17895/72 Heading C2C Nitrobenzyl sulphonates of Formula I in which R is methyl or p-tolyl, are prepared by reacting a nitrobenzyl alcohol with at least an equimolar amount of methanesulphonyl or ptoluenesulphonyl chloride in acetone at 5 to 45‹ C., in the presence of at least an equimolar amount of dicyclohexylamine based on the nitrobenzyl alcohol, separating the precipitate of dicyolohexylamine hydrochloride from the reaction mixture and recovering the desired sulphonate.
[GB1334635A]
Patent IE-820394-L (IE)
Title: Heterocyclic guanidine derivatives
IPC: C07D249/04
Filed: 1982-02-24
Abstract: This invention relates to heterocyclic derivatives which are histamine H-2 antagonists and which inhibit gastric acid secretion. According to the invention there is provided a guanidine derivative of the formula I: <IMAGE> I in which R1 and R2, same or different, are hydrogen or 1-10C alkyl, 3-8C cycloalkyl, 4-14C cycloalkylalkyl, each alkyl, cycloalkyl or cycloalkylalkyl optionally carrying one or more F, Cl or Br atoms, provided that one of R1 and R2 is halogen-substituted, or R2 is hydrogen and R1 is R5-E-W- in which W is 2-6 alkylene optionally substituted by 1 or 2 1-4C alkyls, E is O,S,SO,SO2 or NR6 in which R6 is H or 1-6C alkyl, R5 is H or 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls, or R5 and R6 are joined to form a pyrrolidine, piperidine, morpholine, piperazine or N-methylpiperazine ring; ring X is a heterocyclic ring as defined in the specification; A is phenylene or 5-7C cycloalkylene, or a 1-8C alkylene into which is optionally inserted one or two groups; and R3 and R4 are a variety of radicals described in the specification: and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing processes and pharmaceutical compositions are also described.
[US4795755A]
Patent IE-37415-L (IE)
Title: Distance piece for reinforcing rods
IPC: E04C5/20
Filed: 1973-03-16
Abstract: 1425935 Spacers for reinforcement J P TONER 16 March 1973 [18 March 1972] 12766/72 Heading E1W A reinforcement spacer has a rectangular cross section and comprises two pairs of opposed upstanding side walls 10, 11. Each wall has an upper and a lower support edge lying in a plane normal to the central axis, each of which edges has a recessed portion 12. The upper and lower edges of each pair of walls are offset in the direction of the central axis from the edges of the other pair of walls. Recesses in one end of a pair of walls may be deeper than that recess in the other end so that four spacings may be obtained with the one spacer.
[GB1425935A]
Patent IE-800497-L (IE)
Title: Converting acid salt residues to solid waste products
IPC: C01B25/46
Filed: 1980-03-11
Abstract: The invention relates to a process permitting acid salt residues, hereinafter called raffinates, which are obtained in the decontamination of phosphoric acid by extraction with a solvent, to be converted to solid deposition products, wherein the raffinates are admixed with a quantity of water necessary for them to ensure, after reaction with hydrate of lime or quicklime, the formation of an aqueous filterable suspension. More particularly, the raffinates are admixed with a quantity of hydrate of lime or quicklime necessary for them to ensure, after reaction and filtration of the suspension, the formation of a filter cake having a pH-value within the range 9 to 14. The reaction suspension is filtered as soon as it has assumed a pH-value within the range 5 to 8 and the resulting filter cake is allowed to react completely and deposited.
[US4279876A]
Patent IE-34192-L (IE)
Title: Machine for making strands or cables
IPC: D07B3/04
Filed: 1970-04-30
Abstract: 1,268,315. Tubular stranding machines. BARMAG BARMER MASCHINENFABRIK A.G. 1 May, 1970 [3 May, 1969], No. 21036/ 70. Heading D1T. A stranding machine of the kind in which delivery spools 4, 5 are mounted within an elongated tube 1, and in which one or more window zones 2, 3 are provided in the tube for the insertion and removal of the spools 4, 5, is characterized in that axially displaceable sleeves 10, 11 surround the tube and can be slid to settings in which they close the windows of the tube. Means (not disclosed) are provided to lock each sleeve over its corresponding window zone. Safety switches may be so positioned that when the sleeves are moved away from their respective window zones, the sleeves open the safety switches to prevent the drive to the tube 1 from being energized.
[GB1268315A]
Patent IE-820589-L (IE)
Title: Piperazinylpropyl triazole derivatives
IPC: A61K31/495
Filed: 1982-03-15
Abstract: Phenoxyethyl substituted-1,2,4,-triazolones having antidepressant properties typified by 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyeth yl)-2H-1,2,4-triazol-3(4H)-one are disclosed.
[US4338317A]
Patent IE-900850-L (IE)
Title: Sdk peptides, a preparation process of the same and¹therapeutic compositions containing them
IPC: C07K14/705
Filed: 1990-03-09
Abstract: Peptides having the general formula H2N - W - Ser - Asp - Lys - X - OH (X = Pro, Lys or a direct valence bond; W = Thr, Pro or a direct valence bond; but if X = Pro then W = Pro) have immunomodulatory activity. Their preparation and therapeutic compositions containing them are also described. Peptides specified are:- Ser-Asp-Lys Ser-Asp-Lys-Lys. Pro-Ser-Asp-Lys-Lys. Thr-Ser-Asp-Lys Pro-Ser-Asp-Lys. Thr-Ser-Asp-Lys-Lys Pro-Ser-Asp-Lys-Pro. 
[GB2228937A]
Patent IE-900888-L (IE)
Title: Process for the production of 1,2,2,2-tetrafluoroethyl¹difluoromethyl ether
IPC: B01J27/10
Filed: 1990-03-13
Abstract: A process is provided for the low temperature preparation of CF3CHFOCHF2 which comprises reacting CF3CHClOCHF2 with hydrogen fluoride in the presence of an antimony pentachloride catalyst or mixture of antimony pentachloride and antimony trichloride. The mole ratio of CF3CHClOCHF2 to HF is in the range of about 1.0:0.1 to about 1:7.
Patent FI-831133-L (FI)
Inventor: HUE JEAN
IPC: A63C9/085
Filed: 1983-04-05
Abstract: Binding assembly for a cross country ski boot, having a safety device comprising a hooking arrangement in which the forward end of the boot is retained, and lateral retaining, complementary engaging portions on the ski and in the sole of the boot. The hooking and lateral retaining devices are rigidly affixed to each other without intervening gap, and are releasable at least laterally about at least one rotational axis against the effect of a torsional retainer, whatever the elevation of the boot heel from the ski.